The Effect of Mirror Therapy Applied to Stroke Patients on Motor-Sensory Status and Quality of Life

Purpose: The research will be conducted to evaluate the effect of Mirror Therapy applied to Stroke Patients on motor-sensory status and quality of life.

Method: The research will be carried out as a randomized controlled experimental study at Bilecik Training and Research Hospital and Bozüyük State Hospital between 01.08.2024-01.05.2025. The population of the research consists of 350 people. Individuals will be distributed to the experimental (30) and control (30) groups by simple randomization method. In collecting research data; The patient introduction form, Brunnstrom Staging and SF-36 Quality of Life Scale will be administered to the patients in both groups by the researcher using face-to-face interview technique (pre-test). Patients in the experimental group will be informed about mirror therapy.

In addition to conventional rehabilitation, patients in the experimental group will receive mirror therapy for 30 minutes, 4 times a week for 4 weeks.

Patients in the control group will only receive conventional rehabilitation for 30 minutes, 4 times a week for 4 weeks. At the end of the 4th week, patients in both groups will be administered Brunnstrom Staging and SF-36 Quality of Life Scale (posttest).

If both groups are discharged before 4 weeks, the planned practices will continue at home.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Stroke Brain Diseases Cardiovascular Diseases Central Nervous System Diseases Cerebrovascular Disorders Mirror Movement Therapy Nervous System Diseases Rehabilitation Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Being literate,
Being over the age of 18,
Having sufficient communication skills to answer oral and written questions and follow instructions,
Having been diagnosed with a stroke and at least 6 days have passed since it occurred,
Not having severe vision problems,
Not having a vertigo problem,
Not having been diagnosed with epilepsy,
Upper extremity Stage 2 and above in Brunnstrom staging
Lower extremity Stage 2 and above in Brunnstrom staging

Exclusion criteria

Being under 18 years of age
Upper extremity Stage 2 and below in Brunnstrom staging
In Brunnstrom staging, Lower extremity Stage 2 and below

Treatment and study plan

Conventional rehabilitation will be applied

Behavioral

Conventional rehabilitation will be applied for 30 minutes, 4 times a week for 4 weeks.

Mirror therapy will be applied along with conventional rehabilitation

Behavioral

In addition to conventional rehabilitation, patients in the experimental group will receive mirror therapy for 30 minutes, 4 times a week for 4 weeks.

Primary outcomes

Brunnstrom Motor-Sensory Staging

Time frame: 1 month

Brunnstrom staging, which divides the motor recovery process in hemiplegic patients into 6 periods, was used in the upper extremity motor-sensory evaluation of the patients. Brunnstrom staging; Reveals the stages of recovery of patients from hemiplegia after a stroke. It was developed by Swedish physiatrist Signe Brunnström and highlights the synergistic pattern that develops during recovery from stroke.

Secondary outcomes

SF-36 Quality of Life Scale

Time frame: 1 month

The SF-36 quality of life scale was used to determine the patients' quality of life. The scale was developed by Ware and Sherbourne in 1992. The validity and reliability of the scale in Turkish was conducted by Koçyiğit. Quality of life scale; It contains 36 statements evaluating 2 main dimensions and 8 sub-dimensions. The scale has Likert type scoring. 35 of the 36 statements in the scale are evaluated considering the last 4 weeks.

Sponsors and collaborators

Lead sponsor

Ataturk University

Other

Registry information

Important dates

Study start: 2025
Primary completion: 2026
Study completion: 2026
First posted: May 9, 2025
Registry last updated: May 9, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting